Pubblicazioni 2021

Technological innovation of Continuous Glucose Monitoring (CGM) as a tool for commercial aviation pilots with insulin-treated diabetes and stakeholders/regulators: A new chance to improve the directives?

Sandro Gentile . Giuseppina Guarino . Teresa Della Corte .
Giampiero Marino . Ersilia Satta . Carmine Romano . Carmelo Alfrone .
Clelia lmberti . Felice Strollo . AMD-OSDI Study Group

S. Gentile (&) G. Guarino T. Della Corte G. Marino Department of Internal Medicine, Campania
University ‘‘Luigi Vanvitelli’’, Naples, Italy
e-mail: s.gentile1949@gmail.com

F. Strollo Endocrinology and Diabetes, IRCCS San Raffaele Pisana, Rome, Italy S. Gentile G. Guarino T. Della Corte G. Marino

E. Satta C. Romano C. Alfrone C. lmberti Nefrocenter Research Network & Nyx Start-Up, Naples, Italy

A neglected cause of hypoglycemia in dialysis patients

Sandro Gentile a, c, Ersilia Satta a, d, Felice Strollo a, b, Giuseppina Guarino c, Carmine Romano a, Teresa Della Corte a, c, *, Carmelo Alfarone a, on behalf of Study Group AMD-OSDI on Injection Technique, and Nefrocenter Research & Nyx Start-up

a Nefrocenter Research Network & Nyx Innovative Research Start-Up, Naples, Italy

b Endocrinology and Diabetes, San Raffaele Termini Institute, Rome, Italy

c Department of Internal Medicine, Campania University “Luigi Vanvitelli”, Naples, Italy

d Multi-specialty Nephrology Center (CNP) SrL, Frattamaggiore, Italy

Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review- Based Hypothesis

Vincenzo Maria Monda . Francesca Porcellati . Felice Strollo .

Alessandro Fucili . Marcello Monesi . Ersilia Satta . Sandro Gentile

V. M. Monda
Diabetes Unit ‘‘Santissima Annunziata’’ Hospital
Cento, Ferrara, Italy
e-mail: v.monda@ausl.fe.it

F. Porcellati
Section of Internal Medicine, Endocrinology and
Metabolism, Department of Medicine, Perugia
University School of Medicine, Perugia, Italy
e-mail: f.porcellati.fp@gmail.com

F. Strollo
Endocrinology and Diabetes, IRCCS San Raffaele
Pisana, Rome, Italy
e-mail: felix.strollo@gmail.com

A. Fucili
Cardiovascular Research Center, Ferrara University,
Ferrara, Italy
e-mail: fucilialessandro@gmail.com

M. Monesi
Diabetes Unit ‘‘Sant’Anna’’ Hospital Ferrara, Ferrara,
Italy
e-mail: m.monesi@ospfe.it

E. Satta  S. Gentile
Nefrocenter Research and Nyx Start-Up, Naples,
Italy

E. Satta
Multi-Specialty Nephrology Center (CNP) SrL,
Frattamaggiore, Italy

S. Gentile
Department of Internal Medicine, Campania
University ‘‘Luigi Vanvitelli’’, Caserta, Italy
e-mail: s.gentile1949@gmail.com;
segreteria@nefrocenter.it

Integrated Approach to Cardio-Vascular Risk in Insulin-Treated People with Diabetes based on the “Heart Project” and on Metabolic Complications Expected from Incorrect Injection Practice-Related Lipohypertrophy

Sandro Gentile 1,2, Ersilia Satta 1,3,4, Maurizio Capece 6, Giuseppina Guarino 1,2, Teresa Della Corte 1,2, Carmine Romano 1, Giampiero Marino 2, Maria Pasquarella 1, Carmelo Alfarone 1, Fabrizio Loiacono 5, Rossella Lamberti 7 and Felice Strollo 8 , AMD-OSDI Study Group on Injection Technique and Nefrocenter Research & Nyx Start-Up Study Group

1 Nefrocenter Research s.c. ar. l and Nyx Start-Up, Naples, Italy

2 Department of Internal Medicine, Campania University ‘‘Luigi Vanvitelli’’, Naples, Italy

3 Polispecialistic Nephrological Center CNP Srl, Nefrocenter Network srl. Frattamaggiore, Italy

4 Emodial Center s.r.l. Nefrocenter Network, Naples, Italy

5 Nefrocenter Research s.c. ar. l, Naples, Italy

6 Vomero Center Crisci Bersabea & C S.N.C., Nefrocenter Network, Naples, Italy

7 Metelliano Medical Center, Nefrocenter Network, Naples, Italy

8 Endocrinology and Diabetes, IRCCS San Raffaele Pisana, Rome, Italy